Skip to search boxSkip to navigationSkip to main content

Erratum: Phase I study of bortezomib in refractory or relapsed acute leukemias (Clinical Cancer Research (May 15, 2004) 10 (3371-3377))

  • ,
  • Deborah Thomas
    ,
  • Charles Koller
    ,
  • Frances Giles
    ,
  • Elihu Estey
    ,
  • Stefan Faderl
  • Unknown
Scholary Output:
Contribution to journal
Comment/debate
Peer-review

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Publication Information

Output type

Scholary Output:
Contribution to journal
Comment/debate
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Page 7787 (1 page)

Journal (Volume, Issue Number)

Clinical Cancer Research (Volume 10, Issue 22)

Publication milestones

  • Published - 12/15/2004

Publication status

Published - 12/15/2004

ISSN

1078-0432

Publication IDs

  • Scopus: 9344247475
  • ORCID: /0000-0002-8636-1071/work/68811273

Publication metrics

Metrics

SciVal
citations
1
Scopus
citations
SciVal
FWCI
4.48
SciVal
Author count
12
SciVal
Paper percentile
32
Fractional count
1
Fractional count
0.08
Fractional count
11
Fractional count
0.92
Fractional count
1
Fractional count
1

PlumX

Citation count
1
Captures
2